Table 4.
Comparing adherence measures between African Americans and Caucasians and age‐adjusted odds ratios for high adherence, with Caucasians being the reference group
| Caucasian | AA | OR | 95% CI | P value | Adj OR a | 95% CI | P value | ||
|---|---|---|---|---|---|---|---|---|---|
|
All SLE meds (n = 121) |
Self‐report | 82% | 58% | 0.30 | 0.1‐0.7 | 0.01 | 0.35 | 0.14‐0.87 | 0.02 |
| Refill | 60% | 41% | 0.46 | 0.2‐1.0 | 0.04 | 0.57 | 0.26‐1.2 | 0.16 | |
| Composite | 51% | 30% | 0.42 | 0.2‐0.9 | 0.02 | 0.5 | 0.22‐1.1 | 0.09 | |
|
Prednisone (n = 54) |
Refill | 83% | 57% | 0.27 | 0.05‐1.4 | 0.1 | 0.4 | 0.07‐2.3 | 0.3 |
| Composite | 75% | 36% | 0.19 | 0.04‐0.8 | 0.02 | 0.22 | 0.05‐1.1 | 0.06 | |
|
HCQ (n = 104) |
Refill | 67% | 55% | 0.62 | 0.3‐1.4 | 0.26 | 0.78 | 0.33‐1.8 | 0.6 |
| Composite | 56% | 43% | 0.60 | 0.3‐1.3 | 0.2 | 0.74 | 0.32‐1.7 | 0.5 | |
|
DMARD (n = 71) |
Refill | 64% | 38% | 0.35 | 0.1‐1.0 | 0.05 | 0.39 | 0.13‐1.1 | 0.08 |
| Composite | 45% | 29% | 0.50 | 0.2‐1.3 | 0.2 | 0.6 | 0.2‐1.8 | 0.35 | |
|
MMF (n = 42) |
Refill | 88% | 38% | 0.09 | 0.01‐0.8 | 0.03 | 0.1 | 0.01‐0.9 | 0.04 |
| Composite | 75% | 26% | 0.12 | 0.02‐0.7 | 0.02 | 0.16 | 0.02‐1.0 | 0.05 |
Abbreviation: AA, African American; Adj, adjusted; CI, confidence interval; DMARD, disease‐modifying antirheumatic drugs; HCQ, hydroxychloroquine; meds medications; MMF, mycophenolate; OR, odds ratio; SLE, systemic lupus erythematosus
a
Using Caucasians as the reference group adjusting for age.
Bolded values indicate p‐value <0.05.